📊 OSCR Key Takeaways
Is Oscar Health, Inc. (OSCR) a Good Investment?
Oscar Health demonstrates strong profitability margins (15.2% operating, 14.6% net) and exceptional free cash flow generation (2.6B at 56.2% margin), supported by a fortress balance sheet with conservative leverage (0.26x D/E). However, critical red flags emerge from data inconsistencies: net income growth of 0.0% contradicts claimed 40,824% revenue growth, and severe EPS decline (-1,790%) despite flat earnings indicates substantial shareholder dilution, suggesting underlying operational or structural headwinds.
Oscar has scaled to a large revenue base with strong cash and solid free cash flow despite GAAP losses, indicating meaningful float and low capital intensity. However, margins remain negative with weak ROE and negative interest coverage, so the path to sustained profitability must be demonstrated before fundamentals warrant a more constructive view.
Oscar Health, Inc. Key Strengths (OSCR)
- Exceptional profitability metrics with 40.8% ROE and 14.6% net margin demonstrating strong unit economics
- Outstanding free cash flow generation of 2.6B with 56.2% FCF conversion rate, indicating high-quality earnings
- Conservative balance sheet with 0.26x debt/equity ratio, 4.8B cash position, and 119.3x interest coverage providing financial flexibility
- Robust cash balance and positive free cash flow with low capex needs
- Significant revenue scale and rapid top-line growth
- Moderate leverage (Debt/Equity ~0.44x) providing financial flexibility
OSCR Stock Risks: Oscar Health, Inc. Investment Risks
- Net income stagnation (0.0% YoY growth) despite massive claimed revenue growth suggests potential margin compression, acquisition dilution, or data quality issues
- Catastrophic EPS decline (-1,790%) indicating severe shareholder dilution that destroys per-share economics regardless of absolute profit levels
- Abnormally tight current ratio of 1.09x with high leverage embedded in liabilities despite strong absolute cash position suggests operational cash flow dependency
- Persistent underwriting losses and thin negative margins (net margin -3.8%)
- Regulatory and reimbursement risk in ACA/Medicare markets
- Negative interest coverage and potential capital strain if claims spike
Key Metrics to Watch
- Reconciliation of revenue growth vs. net income growth and underlying driver analysis (pricing, mix, or costs)
- Share count trends and dilution sources over recent quarters relative to equity issuance
- Medical loss ratio and unit economics per member in core markets
- Medical Loss Ratio (MLR)/combined ratio
- Operating margin progression to sustained positive GAAP operating income
Oscar Health, Inc. (OSCR) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The 56.2% free cash flow margin provides substantial flexibility for dividends, buybacks, and strategic investments.
OSCR Profit Margin, ROE & Profitability Analysis
OSCR vs Healthcare Sector: How Oscar Health, Inc. Compares
How Oscar Health, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Oscar Health, Inc. Stock Overvalued? OSCR Valuation Analysis 2026
Based on fundamental analysis, Oscar Health, Inc. appears fundamentally strong relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Oscar Health, Inc. Balance Sheet: OSCR Debt, Cash & Liquidity
OSCR Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Oscar Health, Inc.'s revenue has declined by 53% over the 5-year period, indicating business contraction. The most recent EPS of $-1.22 indicates the company is currently unprofitable.
OSCR Revenue Growth, EPS Growth & YoY Performance
OSCR Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $4.3M | $275.3M | $0.92 |
| Q3 2025 | $4.9M | -$54.6M | $-0.22 |
| Q2 2025 | $5.2M | $46.9M | $0.17 |
| Q1 2025 | $4.3M | $177.4M | $0.62 |
| Q3 2024 | $4.9M | -$54.6M | $-0.22 |
| Q2 2024 | $5.1M | -$15.5M | $-0.07 |
| Q1 2024 | $5.0M | -$39.8M | $-0.18 |
| Q3 2023 | $3.9M | -$65.4M | $-0.29 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Oscar Health, Inc. Dividends, Buybacks & Capital Allocation
OSCR SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Oscar Health, Inc. (CIK: 0001568651)
📋 Recent SEC Filings
❓ Frequently Asked Questions about OSCR
What is the AI rating for OSCR?
Oscar Health, Inc. (OSCR) has a Combined AI Grade of B from Claude (B) and ChatGPT (B) with 61% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are OSCR's key strengths?
Claude: Exceptional profitability metrics with 40.8% ROE and 14.6% net margin demonstrating strong unit economics. Outstanding free cash flow generation of 2.6B with 56.2% FCF conversion rate, indicating high-quality earnings. ChatGPT: Robust cash balance and positive free cash flow with low capex needs. Significant revenue scale and rapid top-line growth.
What are the risks of investing in OSCR?
Claude: Net income stagnation (0.0% YoY growth) despite massive claimed revenue growth suggests potential margin compression, acquisition dilution, or data quality issues. Catastrophic EPS decline (-1,790%) indicating severe shareholder dilution that destroys per-share economics regardless of absolute profit levels. ChatGPT: Persistent underwriting losses and thin negative margins (net margin -3.8%). Regulatory and reimbursement risk in ACA/Medicare markets.
What is OSCR's revenue and growth?
Oscar Health, Inc. reported revenue of $4.6B.
Does OSCR pay dividends?
Oscar Health, Inc. does not currently pay dividends.
Where can I find OSCR SEC filings?
Official SEC filings for Oscar Health, Inc. (CIK: 0001568651) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is OSCR's EPS?
Oscar Health, Inc. has a diluted EPS of $2.07.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is OSCR's fundamental grade?
Based on our AI fundamental analysis in May 2026, Oscar Health, Inc. has a B grade with 61% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is OSCR stock overvalued or undervalued?
Valuation metrics for OSCR: ROE of 40.8% (sector avg: 15%), net margin of 14.6% (sector avg: 12%). Higher ROE suggests strong returns relative to peers.
What is OSCR's AI grade for 2026?
Our dual AI analysis gives Oscar Health, Inc. a combined B grade for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is OSCR's free cash flow?
Oscar Health, Inc.'s operating cash flow is $2.6B, with capital expenditures of $8.8M. FCF margin is 56.2%.
How does OSCR compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin 14.6% (avg: 12%), ROE 40.8% (avg: 15%), current ratio 1.09 (avg: 2).
Why is OSCR's return on equity (ROE) so high?
Oscar Health, Inc. has a return on equity of 40.8%, significantly above the Healthcare sector average of 15%. A high ROE indicates the company is efficient at generating profits from shareholder equity. This is supported by a 14.6% net margin.